The incidence of cancer diagnoses increases with age. One in 5 people in the Western world are over the age of 65y and account for 60% of all cancer diagnoses. Not surprisingly, over half of all cancer survivors are over the age of 65y. Several factors underlie the increased cancer incidence in the elderly. These individuals also have unique cancer screening guidelines, treatment considerations and treatment toxicities. It is important to gain an appreciation of the unique support priorities and strategies for this elderly demographic.
September 24, 2024; 12:00 – 1:00 PM EST
Objectifs d’apprentissage
By the end of this lecture, the clinician will be able to:
- Gain an understanding of the incidence and prevalence of cancer in the older segment of the population
- Understand why cancer is more common in older people
Develop key strategies to address common issues in older people with cancer (renal insufficiency, cardiomyopathy, immunity, etc.)
Crédits CE
CONO: (pending approval) Category A – 0.75 credit (General), 0.25 credit (Pharmacology) Pending approval
British Columbia: Category C – 1.0 credit
AANP: (pending approval) 0.75 credit (General), 0.25 credit (Pharmacy) Pending approval
OANP/OBNM: For Oregon attendees seeking OBNM approved CE credits, please note that this event has not been submitted for approval to the OBNM. CE certificate will be issued upon individual request.
Dr Lise Alschuler, ND, FABNO
Lise Alschuler, ND, FABNO is a Professor of Clinical Medicine at the University of Arizona School of Medicine where she is on the faculty of the Arizona Center for Integrative Medicine. She practices naturopathic oncology out of Naturopathic Specialists, LLC. Dr Alschuler co-hosts a radio show, Five To Thrive Live! and is co-founder of the iTHRIVE Plan, a lifestyle app for cancer survivors. She is co-author of Definitive Guide to Cancer, now in its 3rd edition, and Definitive Guide to Thriving After Cancer.
